Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CWKNASDAQ:MFINYSE:PBHNYSE:PFD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWKCushman & Wakefield$11.85+1.7%$10.38$7.64▼$16.11$2.74B1.431.96 million shs1.10 million shsMFImF International$5.05+600.7%$0.00$0.51▼$6.95$21.15M13.641.09 million shs113,812 shsPBHPrestige Consumer Healthcare$79.98-0.2%$84.17$64.94▼$90.04$3.95B0.43306,436 shs243,045 shsPFDFlaherty & Crumrine Preferred Income Fund$11.43+0.6%$11.11$10.22▼$12.08N/AN/A29,763 shs11,580 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWKCushman & Wakefield0.00%+6.04%+16.46%+31.89%+13.18%MFImF International0.00%-1.37%+107.61%+747.90%+493.53%PBHPrestige Consumer Healthcare0.00%-1.26%-5.47%-3.46%+19.00%PFDFlaherty & Crumrine Preferred Income Fund0.00%+1.28%+2.88%+8.55%+9.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCWKCushman & Wakefield3.9224 of 5 stars2.12.00.02.62.11.73.1MFImF International0.0874 of 5 stars0.02.00.00.00.01.70.0PBHPrestige Consumer Healthcare4.2062 of 5 stars2.34.00.03.52.81.71.9PFDFlaherty & Crumrine Preferred Income FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCWKCushman & Wakefield 2.14Hold$13.4313.32% UpsideMFImF International 0.00N/AN/AN/APBHPrestige Consumer Healthcare 2.50Moderate Buy$93.3316.70% UpsidePFDFlaherty & Crumrine Preferred Income Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CWK, MFI, PFD, DVO, and PBH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/2/2025CWKCushman & WakefieldUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$9.00 ➝ $12.006/12/2025CWKCushman & WakefieldMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$14.00 ➝ $14.505/8/2025PBHPrestige Consumer HealthcareRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold4/24/2025CWKCushman & WakefieldMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $14.004/11/2025CWKCushman & WakefieldUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$14.00 ➝ $9.004/10/2025CWKCushman & WakefieldJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$17.00 ➝ $14.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCWKCushman & Wakefield$9.45B0.29$1.87 per share6.34$7.65 per share1.55MFImF International$3.36M6.31N/AN/A$1.10 per share4.59PBHPrestige Consumer Healthcare$1.14B3.47$5.21 per share15.34$37.04 per share2.16PFDFlaherty & Crumrine Preferred Income Fund$28.93MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCWKCushman & Wakefield$131.30M$0.6917.178.17N/A1.70%13.50%3.11%8/4/2025 (Estimated)MFImF International-$2.60MN/A0.00∞N/AN/AN/AN/AN/APBHPrestige Consumer Healthcare$214.60M$4.2918.6416.802.4018.86%12.87%6.78%8/6/2025 (Estimated)PFDFlaherty & Crumrine Preferred Income FundN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CWK, MFI, PFD, DVO, and PBH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q4 2025PBHPrestige Consumer Healthcare$1.30$1.32+$0.02$1.00$289.36 million$296.52 million4/29/2025Q1 2025CWKCushman & Wakefield$0.02$0.09+$0.07$0.01$2.26 billion$2.28 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCWKCushman & WakefieldN/AN/AN/AN/AN/AMFImF InternationalN/AN/AN/AN/AN/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/APFDFlaherty & Crumrine Preferred Income Fund$0.736.39%N/AN/AN/ALatest CWK, MFI, PFD, DVO, and PBH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/21/2025PFDFlaherty & Crumrine Preferred Income Fund--$0.06226.9%6/23/20256/23/20256/30/20255/20/2025PFDFlaherty & Crumrine Preferred Income Fund$0.06226.72%5/23/20255/26/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCWKCushman & Wakefield1.641.181.18MFImF International0.062.002.00PBHPrestige Consumer Healthcare0.554.202.82PFDFlaherty & Crumrine Preferred Income FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCWKCushman & Wakefield95.56%MFImF InternationalN/APBHPrestige Consumer Healthcare99.95%PFDFlaherty & Crumrine Preferred Income FundN/AInsider OwnershipCompanyInsider OwnershipCWKCushman & Wakefield1.20%MFImF International41.10%PBHPrestige Consumer Healthcare1.40%PFDFlaherty & Crumrine Preferred Income FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCWKCushman & Wakefield52,000231.29 million228.51 millionOptionableMFImF InternationalN/A4.20 million2.48 millionNot OptionablePBHPrestige Consumer Healthcare54049.42 million48.72 millionOptionablePFDFlaherty & Crumrine Preferred Income FundN/AN/AN/ANot OptionableCWK, MFI, PFD, DVO, and PBH HeadlinesRecent News About These CompaniesPFD: Discounted Valuation Due To High LeverageJune 27, 2025 | seekingalpha.comRaise From DFP: Preferred Fund Pays Monthly - 7% YieldJune 2, 2025 | seekingalpha.comPFD, PFO, FFC, FLC and DFP Announce Dividends for May, June and JulyApril 16, 2025 | businesswire.comRaymond James Downgrades Synovus Financial - Preferred Stock (SNV.PRE)April 3, 2025 | msn.comRithm Capital Has 4 Preferreds: B Is My Pick NowMarch 3, 2025 | seekingalpha.comDFP: Hard To Make A Case For This Preferred FundFebruary 11, 2025 | seekingalpha.comHow To Trade (PFD)January 27, 2025 | news.stocktradersdaily.comN(PFD) Investment ReportJanuary 8, 2025 | news.stocktradersdaily.comN(PFD) Pivots Trading Plans and Risk ControlsDecember 17, 2024 | news.stocktradersdaily.comNWhen the Price of (PFD) Talks, People ListenDecember 6, 2024 | news.stocktradersdaily.comNBEPR:CA Brompton Flaherty & Crumrine Enhanced Investment Grade Preferred ETFNovember 28, 2024 | seekingalpha.com(PFD) Trading ReportNovember 25, 2024 | news.stocktradersdaily.comNLong Term Trading Analysis for (PFD)November 4, 2024 | news.stocktradersdaily.comNBrompton Funds Announces Termination of Distribution Reinvestment Plan for Its Exchange Traded FundsOctober 31, 2024 | markets.businessinsider.comDestra Flaherty & Crumrine Preferred And Income Fund Class A (0P0000SGBZ)October 28, 2024 | uk.investing.comTrading (PFD) With Integrated Risk ControlsOctober 23, 2024 | news.stocktradersdaily.comNFlaherty & Crumrine Preferred and Income Securities Fund Incorporated raises monthly dividend by 2.6% to $0.092/shareOctober 18, 2024 | msn.comWells Fargo Initiates Coverage of Raymond James Financial, Inc. - Preferred Stock (RJF.PRB) with Overweight RecommendationSeptember 14, 2024 | msn.comDestra Flaherty & Crumrine Pref & Inc CSeptember 11, 2024 | morningstar.comMFlaherty & Crumrine Preferred Income Fund Inc (PFD)September 11, 2024 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCWK, MFI, PFD, DVO, and PBH Company DescriptionsCushman & Wakefield NYSE:CWK$11.85 +0.20 (+1.72%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$11.84 0.00 (-0.04%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America. The EMEA segment includes operations in the UK, France, Netherlands and other markets in Europe and the Middle East. The APAC segment comprises of operations in Australia, Singapore, China and other markets in the Asia Pacific region. The company was founded in 1917 and is headquartered in London, the United Kingdom.mF International NASDAQ:MFIMicroFinancial Incorporated (MicroFinancial) operates through its wholly-owned subsidiaries, TimePayment Corp. (TimePayment) and Leasecomm Corporation (Leasecomm). TimePayment is a specialized commercial/consumer finance company that leases and rents equipment, and provides other financing services, with a focus on the microticket market. TimePayment finances a variety of products, including water filtration systems, food service equipment, security equipment, point of sale (POS) cash registers, salon equipment, copiers, health care and fitness equipment, and automotive repair equipment. The Company provides financing alternatives to a range of lessees ranging from start-up businesses to established enterprises.Prestige Consumer Healthcare NYSE:PBH$79.98 -0.20 (-0.25%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$79.82 -0.16 (-0.19%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.Flaherty & Crumrine Preferred Income Fund NYSE:PFD$11.43 +0.07 (+0.62%) As of 07/3/2025 03:30 PM EasternFlaherty & Crumrine Preferred Income Fund Inc. is a closed ended equity mutual fund launched and managed by Flaherty & Crumrine Incorporated. The fund invests in the public equity markets of the United States. It invests in the stocks of companies operating in the financials sector. The fund primarily invests in preferred securities. It benchmarks the performance of its portfolio against the Barclays Capital U.S. Aggregate Index and S&P 500 Index. Flaherty & Crumrine Preferred Income Fund Inc was formed on September 28, 1990 and is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
